Cross-sectorial Use of Patient-Reported Outcomes in Chronic Degenerative Shoulder Conditions
Launched by UNIVERSITY HOSPITAL, GENTOFTE, COPENHAGEN · May 23, 2024
Trial Information
Current as of September 15, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study is asking whether regularly using patient-reported outcomes (PROs)—simple questionnaires about your pain, function, and overall well-being—across different health care providers helps people with chronic shoulder problems. It will compare two groups: one where PRO results are used to guide treatment (the intervention) and a control group where PRO results are collected but not used during treatment. Participants will complete PROs every 3 months for 2 years. The main thing the researchers will compare is cost per unit of improvement in life quality over the two years, using a standard health score and counting costs from hospital visits, physical therapy, and primary care.
Eligible participants are adults 18 years and older with ongoing shoulder pain from degenerative or non-acute conditions (such as bursitis, shoulder impingement, rotator cuff issues, osteoarthritis, frozen shoulder, or related problems). Key criteria include being able to understand Danish, using electronic communications, and not having factors that could bias consent or response (for example, certain medical or life situations or involvement with participating centers). The trial is taking place in Denmark at several sites, aiming to enroll about 1,000 people starting in 2024, with results anticipated after the 2-year follow-up. No results are available yet.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • shoulder pain with no acute trauma
- Exclusion Criteria:
- • Age \<18 years
- • Non-Danish citizenship
- • Unable to understand written or spoken Danish
- • Inability to master electronic means of communication and/or not having an electronic communication (E-boks)
- • Employee at participating centre or other relation to participating health professionals that might affect independent consent
- • Psychiatric conditions, mental conditions and substance abuse that might affect the ability to provide informed consent or responding to PROMs
- • Disseminated malignant condition, other serious medical conditions or other life crisis where the focus on a shoulder research project is unreasonable
- • Already included in the study with the contralateral shoulder
About University Hospital, Gentofte, Copenhagen
University Hospital Gentofte, located in Copenhagen, is a leading academic medical center renowned for its commitment to advanced healthcare and innovative research. As a prominent sponsor of clinical trials, the hospital integrates cutting-edge medical practices with rigorous scientific inquiry, facilitating the development of new therapies and treatment protocols. With a multidisciplinary team of experts and state-of-the-art facilities, University Hospital Gentofte plays a pivotal role in enhancing patient care and contributing to the global medical community through its dedication to clinical research and education.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Gentofte, Hellerup, Denmark
Hellerup, Denmark
Hellerup, Denmark
Rødovre, Denmark
Rødovre, Denmark
Charlottenlund, Denmark
Patients applied
Trial Officials
Anders Odgaard, MD, DrMed
Study Director
Rigshospitalet, Denmark
Anne M Nyholm, MD, PhD
Principal Investigator
University Hospital, Gentofte, Copenhagen
Bo S Olsen, MD, PhD
Study Chair
University Hospital, Gentofte, Copenhagen
Carsten B Juhl, PT, MPH, PhD
Study Chair
University Hospital, Gentofte, Copenhagen
Bente A Esbensen, Cand.cur., PhD
Study Chair
Rigshospitalet, Denmark
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported